Cargando…
Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies
Conventional type 1 dendritic cells (cDC1s) are superior in antigen cross-presentation and priming CD8(+) T cell anti-tumor immunity and thus, are a target of high interest for cancer immunotherapy. Type I interferon (IFN) is a potent inducer of antigen cross-presentation, but, unfortunately, shows...
Autores principales: | Noe, Paul, Wang, Joy H., Chung, Kyu, Cheng, Zhiyong, Field, Jessica J., Shen, Xiaomeng, Cortesio, Christa L., Pastuskovas, Cinthia V., Phee, Hyewon, Tarbell, Kristin V., Egen, Jackson G., Casbon, Amy-Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628189/ https://www.ncbi.nlm.nih.gov/pubmed/37942313 http://dx.doi.org/10.3389/fimmu.2023.1272055 |
Ejemplares similares
-
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
por: Noubade, Rajkumar, et al.
Publicado: (2019) -
Crucial roles of XCR1-expressing dendritic cells and the XCR1-XCL1 chemokine axis in intestinal immune homeostasis
por: Ohta, Tomokazu, et al.
Publicado: (2016) -
The role of the chemokine receptor XCR1 in breast cancer cells
por: Yang, Xiao Li, et al.
Publicado: (2017) -
Development and function of chicken XCR1(+) conventional dendritic cells
por: Wu, Zhiguang, et al.
Publicado: (2023) -
Ontogenic, Phenotypic, and Functional Characterization of XCR1(+) Dendritic Cells Leads to a Consistent Classification of Intestinal Dendritic Cells Based on the Expression of XCR1 and SIRPα
por: Becker, Martina, et al.
Publicado: (2014)